undefined
EUTM file information

019101175

MERIBEL


November 3, 2024

Trademark Summary

The trademark application MERIBEL was filed by BW CDMO Holdings UK Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). Application filed.

The application was filed in English (French was selected as the second language).


Goods And Services

  • The mark was filed in class 40 with following description of goods:
    1. Custom manufacture of pharmaceuticals
    2. Custom manufacture of medicines and vaccines
    3. Custom manufacture of products relating to biotechnology
    4. Custom manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders
    5. Custom manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products
    6. Contract manufacturing services
    7. Pharmaceutical contract manufacturing services
    8. Biotechnology contract manufacturing services
    9. Contract manufacture of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders
    10. Contract manufacture of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products.
  • The mark was filed in class 42 with following description of goods:
    1. Scientific and technological services and research and design relating thereto
    2. Industrial analysis services
    3. Laboratory services
    4. Research and development services
    5. Pharmaceutical research and development services
    6. Research and development in the biotechnology field
    7. Biological research, clinical research and medical research
    8. Scientific research and development
    9. Scientific research in the field of biotechnology and pharmaceuticals
    10. Conducting clinical trials
    11. Pharmaceutical testing and clinical trials
    12. Pharmaceutical drug developments services
    13. Research and development of pharmaceutical preparations
    14. Research and development of vaccines and medicines
    15. Research and development of gene-based medicines
    16. Research and laboratory analytic and diagnostic services
    17. Design of manufacturing facilities
    18. Manufacturing development services
    19. Quality control and validation services
    20. Genetic engineering laboratories and biochemistry laboratories
    21. Product development consultancy in the field of pharmaceuticals
    22. Product development consultancy in the field of nanotechnology, gene therapy and vector-based delivery systems
    23. Product, viral vector and analytic assay development for others
    24. Product development consultancy in the field of pharmaceuticals and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders
    25. Product development consultancy in the field of gene therapy, and viral, retroviral, lentiviral and non-viral preparations and biopharmaceutical products
    26. Provision of information relating to scientific research
    27. Provision of scientific information
    28. Research and scientific analysis relating to drug discovery and development for others
    29. Scientific advisory services
    30. Scientific consultancy
    31. Pharmaceutical consultancy
    32. Management of scientific research projects
    33. Management of pharmaceutical projects
    34. Issuing of scientific information
    35. Provision of information and consultancy in relation to the aforesaid services.